Diametric Capital, LP

SEC CIK: 0001719087
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by Diametric Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overview All 13F holders of ACRS Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of ACRS by Diametric Capital, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−30,137−100.0%	Sold out	Holders
Q1 2025	30,137	$46.1K	0.1%	+30,137	New	Holders
Q2 2021	0	$0	0.0%	−11,038−100.0%	Sold out	Holders
Q1 2021	11,038	$278.0K	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.